Mirikizumab pharmacokinetics and exposure-response in pediatric patients with moderate-to-severe ulcerative colitis
PMID: 39693227
Source: CPT Pharmacometrics Syst Pharmacol
Publication date:
2025-07-24
Year:
2025
Abstract
NULL